[Substances inhibiting fibrinolysis].
D000614:Aminocaproates / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000933:Antifibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use; D007611:Aprotinin / Q000494:pharmacology / Q000627:therapeutic use; D005112:Extracorporeal Circulation; D005260:Female; D006470:Hemorrhage / Q000188:drug therapy; D006474:Hemorrhagic Disorders / Q000188:drug therapy; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy; D010447:Peptide Hydrolases / Q000494:pharmacology / Q000627:therapeutic use; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy; D011833:Radiation Injuries, Experimental / Q000188:drug therapy; D013345:Subarachnoid Hemorrhage / Q000188:drug therapy; D014945:Wound Healing
D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D007611:Aprotinin; D010447:Peptide Hydrolases
Veshchestva, ugnetaiushchie fibrinoliz.